Jiangsu Hualan Stock Hits Day Low Amid Price Pressure, Closes at CNY 79.80

Jiangsu Hualan New Pharmaceutical Material Co., Ltd. experienced a notable decline today, with its stock price dropping by 3.29% on March 3, 2026. The stock reached an intraday low of CNY 79.80, reflecting a challenging trading environment for the company. Despite a strong performance over the past year, where the stock surged by 324.18%, recent trends indicate a struggle for the company. The one-day performance contrasts sharply with the China Shanghai Composite, which fell by only 1.26%. Over the past week, Jiangsu Hualan saw a modest increase of 3.54%, but its one-month performance shows a slight decline of 1.16%. Key financial metrics reveal concerns regarding the company's management efficiency, with a Return on Capital Employed (ROCE) of just 9.64%. Additionally, the company has reported negative results for the last three consecutive quarters, with a significant drop in net profit. The current market capitalization stands at CNY 12,456 million, and the stock carries a high Price to Earnings (P/E) ratio of 151.00, indicating potential valuation concerns.